Contact this trialFirst, we need to learn more about you.
Hormone Therapy
Apalutamide + Cetrelimab for Prostate Cancer
Recruiting1 awardPhase 2
San Francisco, California
This trial is testing whether combining apalutamide with cetrelimab will result in a better response rate for men with metastatic castration-resistant prostate cancer who have evidence of treatment-emergent small cell neuroendocrine prostate cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.